| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 71.86B | 72.60B | 68.39B | 65.62B | 53.51B | 51.25B |
| Gross Profit | 11.70B | 12.16B | 10.97B | 8.98B | 6.59B | 6.51B |
| EBITDA | 4.24B | 5.49B | 6.45B | 4.33B | 2.85B | 2.58B |
| Net Income | 1.88B | 2.76B | 3.22B | 1.02B | 510.00M | -433.00M |
Balance Sheet | ||||||
| Total Assets | 54.15B | 54.27B | 53.86B | 51.55B | 50.28B | 46.85B |
| Cash, Cash Equivalents and Short-Term Investments | 6.80B | 6.31B | 5.29B | 4.42B | 2.39B | 5.66B |
| Total Debt | 14.06B | 11.39B | 13.01B | 14.37B | 16.61B | 14.28B |
| Total Liabilities | 29.93B | 29.31B | 31.30B | 33.10B | 33.02B | 30.57B |
| Stockholders Equity | 24.20B | 24.93B | 22.54B | 18.43B | 17.25B | 16.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.74B | 2.16B | 4.54B | -5.31B | 1.89B |
| Operating Cash Flow | 0.00 | 4.29B | 3.17B | 6.27B | -1.02B | 3.49B |
| Investing Cash Flow | 0.00 | -1.18B | -725.00M | -1.46B | -4.19B | -1.02B |
| Financing Cash Flow | 0.00 | -2.25B | -1.90B | -2.70B | 1.74B | -221.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥24.71B | 8.95 | ― | 3.65% | 0.13% | 49.05% | |
77 Outperform | ¥30.01B | 12.88 | ― | 4.20% | -1.15% | -34.09% | |
75 Outperform | ¥6.66B | 8.95 | ― | 2.64% | 2.28% | 41.72% | |
73 Outperform | ¥166.35B | 23.86 | ― | 5.78% | -4.26% | 17.85% | |
66 Neutral | ¥44.97B | 77.23 | ― | 5.35% | -6.20% | -64.65% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥3.69B | -146.23 | ― | 3.03% | 4.17% | -693.96% |